Strongest Alzheimer's Phase 3 data release to date Association underscores urgent call for CMS to stop blocking access to FDA-approved...

Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...

Bipartisan members sharply question CMS Administrator why Alzheimer’s drugs aren’t reasonable and necessary Washington, D.C., April 26, 2023 — Today...

For over a year, the Centers for Medicare & Medicaid Services (CMS) has been blocking access to Food and Drug...

In communities across the nation, Alzheimer’s Association advocates are building on the momentum from the AIM Advocacy Forum and calling...

Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...